The potential limit is the high CD7 expression on normal lymphocytes, but Gomes-Silva et al. demonstrated that the use of CD7-directed CAR-T cells in CD7 gene-knockout T cells can eliminate AML cells [74]. This evidence concerns the gene CD7 and acute myeloid leukemia.